+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Messenger RNA (mRNA) Vaccines & Therapeutics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

  • PDF Icon

    Report

  • 125 Pages
  • November 2022
  • Region: Global
  • Renub Research
  • ID: 5696926

Messenger RNA (mRNA) Vaccines & Therapeutics Market Size, Global Forecast 2023-2028

Global Messenger RNA (mRNA) Vaccines & Therapeutics Market will reach US$ 26.34 Billion by 2028. Messenger Ribonucleic Acid (mRNA) is a term that refers to a single protein-coding gene in the genome that conforms as the basis for protein synthesis in cells. mRNA vaccines and treatments are made in laboratories utilizing mammalian cells and have favorable immunological characteristics. Infection prevention mRNA vaccines, infectious disease treatment mRNA vaccines, customized cancer therapy mRNA vaccines, and standardization of cancer treatment mRNA vaccines are frequent types of vaccinations and therapies. They are injected into the body to activate virus-detecting immunological sensors and cause the cells to generate viral antigen proteins. This improves B- and T-cell responses, which helps the body's immunity.

Global Messenger RNA (mRNA) Vaccines & Therapeutics Market Size will expand at a CAGR of 14.60% from 2022 to 2028:

mRNA vaccines and treatments are generated employing new technologies that are more effective against infections, have higher potency, improved immunogenicity, and are relatively more cost-effective than conventional pharmaceuticals. One of the critical factors propelling the development of the Global Messenger RNA (mRNA) Vaccines & Therapeutics Market is the increased prevalence of medical disorders such as diabetes, TB, cancer, and cardiovascular diseases (CVDs). In addition, the industry also benefits from rising demand for therapeutic drugs and vaccines for Ebola, influenza, HIV, and other viral illnesses.

Evolution of the Global Messenger RNA (mRNA) Vaccines & Therapeutics Industry amidst Pandemic:

With the launch and widespread usage of mRNA vaccines and therapies for COVID-19, 2020 marked a watershed moment for mRNA technology platforms. As a result, the combined market valuation of mRNA platforms had increased fast by 2020. The increase in market value reflects expectations that mRNA technology will give far more than the current COVID-19 preventive vaccines. according to the publisher, the Global Messenger RNA (mRNA) Vaccines and Therapeutics Market was valued at US$ 11.63 Billion in 2022.

Global Messenger RNA (mRNA) Vaccines & Therapeutics Market: Segmentation Analysis:

By Type, the market is bifurcated into Infection Prevention mRNA Vaccine, Infectious Disease Treatment mRNA Vaccine, Individualized Cancer Treatment mRNA Vaccine, and Standardization of Cancer Treatment mRNA Vaccine.

By Application, Cancer, Infectious Diseases, and Others are the major segments covered in our report. As per our estimates, Infectious Diseases hold a significant share in the market and are estimated to remain dominant throughout the forecasted period.

By End User, we have studied the market for hospitals, Clinics, Diagnostics Centers, and Others. As per our analysis, clinics and diagnostic centers are gaining traction with the advancement of technology applications. However, hospitals tend to remain dominant throughout the study period.

By Region, North America, Europe, Asia-Pacific, and Rest of the World. During the forecast period, North America is estimated to monopolize the Global Messenger RNA (mRNA) Vaccines & Therapeutics Market. The market in North America is contrived by an increase in demand for COVID-19 mRNA vaccines, major players operating in the US, and an exponential rise in the number of COVID-19 cases in the US.

Key Players:

Pfizer, GlaxoSmithKline, Daiichi Sankyo Company, Limited, Intellia Therapeutics, Moderna Inc, CureVac N.V., Arcturus Therapeutics Holdings, and BioNTech are the prominent companies in the Global Messenger RNA (mRNA) Vaccines & Therapeutics Market examined in our analysis. In addition, we have discussed the competition landscape section of the study, which included an overview, the latest development strategies, and market revenue analysis of the above-mentioned worldwide companies. Surprisingly, the major firms invest in mRNA technologies since they can integrate numerous molecules into a therapeutic drug, which is a huge growth factor.

The publisher's latest report “Global Messenger RNA (mRNA) Vaccines & Therapeutics Market, Global Forecast By Type (Infection Prevention mRNA Vaccine, Infectious Disease Treatment mRNA Vaccine, Individualized Cancer Treatment mRNA Vaccine and Standardization of Cancer Treatment mRNA Vaccine), Application (Cancer, Infectious Diseases and Others), End User (Hospital, Clinics, Diagnostics Centers and Others), Region (North America, Europe, Asia-Pacific and Rest of the World), Companies (Pfizer, GlaxoSmithKline, Daiichi Sankyo Company, Limited, Intellia Therapeutics, Moderna Inc, CureVac N.V., Arcturus Therapeutics Holdings, and BioNTech)” provides a detailed analysis of Global Messenger RNA (mRNA) Vaccines & Therapeutics Industry.

Type - The market has been studied from 4 viewpoints:

1. Infection Prevention mRNA Vaccine
2. Infectious Disease Treatment mRNA Vaccine
3. Individualized Cancer Treatment mRNA Vaccine
4. Standardization of Cancer Treatment mRNA Vaccine

Application - The market has been studied from 3 viewpoints:

1. Cancer
2. Infectious Diseases
3. Others

End Use - The market has been studied from 4 viewpoints:

1. Hospital
2. Clinics
3. Diagnostics Centers
4. Others

Region - The market has been studied from 4 viewpoints:

1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World

Company Insights:

  • Overview
  • Recent Development
  • Revenue

Key Players:

1. Pfizer
2. GlaxoSmithKline's
3. Daiichi Sankyo Company, Limited.
4. Intellia Therapeutics
5. Moderna Inc
6. CureVac N.V.
7. Arcturus Therapeutics Holdings
8. BioNTech

Table of Contents


1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities
5. Global Messenger RNA (mRNA) Vaccines & Therapeutics Market
6. Share Analysis - Global Messenger RNA (mRNA) Vaccines & Therapeutics Market
6.1 By Type
6.2 By Application
6.3 By End User
6.4 By Region
7. Type - Global Messenger RNA (mRNA) Vaccines & Therapeutics Market
7.1 Infection Prevention mRNA Vaccine
7.2 Infectious Disease Treatment mRNA Vaccine
7.3 Individualized Cancer Treatment mRNA Vaccine
7.4 Standardization of Cancer Treatment mRNA Vaccine
8. Application - Global Messenger RNA (mRNA) Vaccines & Therapeutics Market
8.1 Cancer
8.2 Infectious Diseases
8.3 Others
9. End User - Global Messenger RNA (mRNA) Vaccines & Therapeutics Market
9.1 Hospital
9.2 Clinics
9.3 Diagnostics Centers
9.4 Others
10. Region - Global Messenger RNA (mRNA) Vaccines & Therapeutics Market
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. Key Players
11.1 Pfizer
11.1.1 Overview
11.1.2 Recent Development
11.1.3 Revenue
11.2 GlaxoSmithKline's
11.2.1 Overview
11.2.2 Recent Development
11.2.3 Revenue
11.3 Daiichi Sankyo Company, Limited.
11.3.1 Overview
11.3.2 Recent Development
11.3.3 Revenue
11.4 Intellia Therapeutics
11.4.1 Overview
11.4.2 Recent Development
11.4.3 Revenue
11.5 Moderna Inc
11.5.1 Overview
11.5.2 Recent Development
11.5.3 Revenue
11.6 CureVac N.V.
11.6.1 Overview
11.6.2 Recent Development
11.6.3 Revenue
11.7 Arcturus Therapeutics Holdings
11.7.1 Overview
11.7.2 Recent Development
11.7.3 Revenue
11.8 BioNTech
11.8.1 Overview
11.8.2 Recent Development
11.8.3 Revenue
List of Figures
Figure 01: Global - Messenger RNA (mRNA) Vaccines & Therapeutics Market (Billion US$), 2017 - 2022
Figure 02: Global - Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market (Billion US$), 2023 - 2028
Figure 03: Type - Infection Prevention mRNA Vaccine Market (Million US$), 2017 - 2022
Figure 04: Type - Forecast for Infection Prevention mRNA Vaccine Market (Million US$), 2023 - 2028
Figure 05: Type - Infectious Disease Treatment mRNA Vaccine Market (Million US$), 2017 - 2022
Figure 06: Type - Forecast for Infectious Disease Treatment mRNA Vaccine Market (Million US$), 2023 - 2028
Figure 07: Type - Individualized Cancer Treatment mRNA Vaccine Market (Million US$), 2017 - 2022
Figure 08: Type - Forecast for Individualized Cancer Treatment mRNA Vaccine Market (Million US$), 2023 - 2028
Figure 09: Type - Standardization of Cancer Treatment mRNA Vaccine Market (Million US$), 2017 - 2022
Figure 10: Type - Forecast for Standardization of Cancer Treatment mRNA Vaccine Market (Million US$), 2023 - 2028
Figure 11: Application - Cancer Market (Million US$), 2017 - 2022
Figure 12: Application - Forecast for Cancer Market (Million US$), 2023 - 2028
Figure 13: Application - Infectious Diseases Market (Million US$), 2017 - 2022
Figure 14: Application - Forecast for Infectious Diseases Market (Million US$), 2023 - 2028
Figure 15: Application - Others Market (Million US$), 2017 - 2022
Figure 16: Application - Forecast for Others Market (Million US$), 2023 - 2028
Figure 17: End User - Hospital Market (Million US$), 2017 - 2022
Figure 18: End User - Forecast for Hospital Market (Million US$), 2023 - 2028
Figure 19: End User - Clinics Market (Million US$), 2017 - 2022
Figure 20: End User - Forecast for Clinics Market (Million US$), 2023 - 2028
Figure 21: End User - Diagnostics Centers Market (Million US$), 2017 - 2022
Figure 22: End User - Forecast for Diagnostics Centers Market (Million US$), 2023 - 2028
Figure 23: End User - Others Market (Million US$), 2017 - 2022
Figure 24: End User - Forecast for Others Market (Million US$), 2023 - 2028
Figure 25: North America - Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2017 - 2022
Figure 26: North America - Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2023 - 2028
Figure 27: Europe - Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2017 - 2022
Figure 28: Europe - Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2023 - 2028
Figure 29: Asia-Pacific - Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2017 - 2022
Figure 30: Asia-Pacific - Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2023 - 2028
Figure 31: Rest of the World - Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2017 - 2022
Figure 32: Rest of the World - Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market (Million US$), 2023 - 2028
Figure 33: Pfizer - Global Revenue (Billion US$), 2017 - 2022
Figure 34: Pfizer - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 35: GlaxoSmithKline's - Global Revenue (Billion US$), 2017 - 2022
Figure 36: GlaxoSmithKline's - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 37: Daiichi Sankyo Company, Limited. - Global Revenue (Billion US$), 2017 - 2022
Figure 38: Daiichi Sankyo Company, Limited. - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 39: Intellia Therapeutics - Global Revenue (Million US$), 2017 - 2022
Figure 40: Intellia Therapeutics - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 41: Moderna Inc - Global Revenue (Million US$), 2017 - 2022
Figure 42: Moderna Inc - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 43: CureVac N.V. - Global Revenue (Million US$), 2017 - 2022
Figure 44: CureVac N.V. - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 45: Arcturus Therapeutics Holdings - Global Revenue (Million US$), 2017 - 2022
Figure 46: Arcturus Therapeutics Holdings - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 47: BioNTech - Global Revenue (Million US$), 2017 - 2022
Figure 48: BioNTech - Forecast for Global Revenue (Million US$), 2023 - 2028
List of Tables
Table 01: Global - Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Type (Percent), 2017 - 2022
Table 02: Global - Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Type (Percent), 2023 - 2028
Table 03: Global - Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Application (Percent), 2017 - 2022
Table 04: Global - Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Application (Percent), 2023 - 2028
Table 05: Global - Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by End User (Percent), 2017 - 2022
Table 06: Global - Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by End User (Percent), 2023 - 2028
Table 07: Global - Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Region (Percent), 2017 - 2022
Table 08: Global - Forecast for Messenger RNA (mRNA) Vaccines & Therapeutics Market Share by Region (Percent), 2023 - 2028

Companies Mentioned

  • Pfizer
  • GlaxoSmithKline's
  • Daiichi Sankyo Company, Limited.
  • Intellia Therapeutics
  • Moderna Inc
  • CureVac N.V.
  • Arcturus Therapeutics Holdings
  • BioNTech

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...